Compare Schlumberger NV (SLB) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Schlumberger NV vs 10X Genomics Inc — how do they compare? Schlumberger NV trades at $46.77 (market cap $69.36B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Schlumberger NV is far larger — about 12.7× 10X Genomics Inc's market cap, and Schlumberger NV pays a 2.54% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| SLB | TXG | |
|---|---|---|
Market Cap | $69.36B | $5.48B |
Sector | Energy | Health |
52-Week High | $58.01 | $45.80 |
52-Week Low | $31.72 | $11.34 |
Enterprise Value | $77.58B | $5.02B |
Dividend Yield | 2.54% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
